Helicobacter pylori CagA toxin polymorphism

幽门螺杆菌CagA毒素多态性

基本信息

项目摘要

 DESCRIPTION (provided by applicant): H. pylori chronically infects more than 50% of the world's population and is a significant cause of gastritis, peptic ulcer disease and gastric cancer Within the gastric niche, the bacterium interacts with host cells and elaborates a number of virulence factors that influence disease etiology. Chief among these pathogenic determinants is the cytotoxin-associated gene A product, CagA, a protein that is injected into host cells via a Type IV secretion system. Once inside host cells, CagA is tyrosine phosphorylated by host cell Src/Lyn kinases and subsequently alters host cell physiology via interaction with Src homology region 2, phosphatase 2 (SHP-2) and disruption of multiple signaling pathways. These changes are believed to be central to development of H. pylori-induced disease since epidemiological data indicate that persons infected with CagA-positive strains of H. pylori are significantly more likely to develop severe forms of gastric disease than individuals who harbor CagA-negative isolates. Additionally, the C-terminal portion of CagA is polymorphic specifically in the region that undergoes tyrosine phosphorylation. Epidemiologic evidence and in vitro tissue culture studies indicate that this natural CagA polymorphism may be a crucial determinant for the predisposition of infected individuals to develop gastric cancer. However, all of the cell culture studies that have linked CagA polymorphism to enhanced H. pylori modulation of host cell pathways have either used nonisogenic strains of H. pylori or relied upon transfection models. Interpretation of these study results is complicated by the fact that H. pylori shows a remarkably high degree of strain variation, and transfection studies likely do not accurately mimic bacterial delivery of CagA during the course of a natural infection. Our lab has designed and constructed isogenic strains of H. pylori that differ only in the C-terminal phosphorylation domain of the CagA protein and herein we propose to use these novel strains to aid our long term goal of understanding H. pylori pathogenesis by defining the role of CagA polymorphism in host cell changes and disease development using a short-term gastric cancer small animal model.
 描述(由申请人提供):H。幽门螺杆菌慢性感染超过50%的世界人口,并且是胃炎、消化性溃疡疾病和胃癌的重要原因。在胃生态位内,细菌与宿主细胞相互作用,并产生影响疾病病因的许多毒力因子。这些致病决定因素中的主要是细胞毒素相关基因A产物CagA,一种通过IV型分泌系统注入宿主细胞的蛋白质。一旦进入宿主细胞,CagA被宿主细胞Src/林恩激酶酪氨酸磷酸化,随后通过与Src同源区2、磷酸酶2(SHP-2)的相互作用和多种信号传导途径的破坏来改变宿主细胞生理学。这些变化被认为是H. pylori引起的疾病,因为流行病学数据表明感染CagA阳性H.幽门螺杆菌感染者比携带CagA阴性分离株的个体更容易患上严重的胃病。此外,CagA的C-末端部分是多态性的,特别是在经历酪氨酸磷酸化的区域。流行病学证据和体外组织培养研究表明,这种天然CagA多态性可能是受感染个体发生胃癌的易感性的关键决定因素。然而,所有将CagA多态性与H.幽门螺杆菌调节宿主细胞途径使用了H. pylori感染或依赖于转染模型。这些研究结果的解释是复杂的事实,H。幽门螺杆菌显示出显著高度的菌株变异,并且转染研究可能不能准确地模拟自然感染过程中CagA的细菌递送。本实验室设计并构建了H. pylori的不同之处仅在于CagA蛋白的C-末端磷酸化结构域,在此,我们建议使用这些新菌株来帮助我们理解H. pylori发病机制,通过使用短期胃癌小动物模型定义CagA多态性在宿主细胞变化和疾病发展中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

D. SCOTT MERRELL其他文献

D. SCOTT MERRELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('D. SCOTT MERRELL', 18)}}的其他基金

Contribution of Helicobacter pylori HomA and HomB to colonization and disease
幽门螺杆菌 HomA 和 HomB 对定植和疾病的贡献
  • 批准号:
    10301421
  • 财政年份:
    2021
  • 资助金额:
    $ 22.9万
  • 项目类别:
Helicobacter pylori CagA toxin polymorphism
幽门螺杆菌CagA毒素多态性
  • 批准号:
    9252373
  • 财政年份:
    2016
  • 资助金额:
    $ 22.9万
  • 项目类别:
Bacterial and Chemical Carcinogens in Gastric Oncogenesis
胃肿瘤发生中的细菌和化学致癌物
  • 批准号:
    8271317
  • 财政年份:
    2009
  • 资助金额:
    $ 22.9万
  • 项目类别:
Regulatory Networks of Helicobacter pylori
幽门螺杆菌的调节网络
  • 批准号:
    7993513
  • 财政年份:
    2006
  • 资助金额:
    $ 22.9万
  • 项目类别:
Regulatory Networks of Helicobacter pylori
幽门螺杆菌的调控网络
  • 批准号:
    7196334
  • 财政年份:
    2006
  • 资助金额:
    $ 22.9万
  • 项目类别:
Regulatory Networks of Helicobacter pylori
幽门螺杆菌的调控网络
  • 批准号:
    7329166
  • 财政年份:
    2006
  • 资助金额:
    $ 22.9万
  • 项目类别:
Regulatory Networks of Helicobacter pylori
幽门螺杆菌的调控网络
  • 批准号:
    7545907
  • 财政年份:
    2006
  • 资助金额:
    $ 22.9万
  • 项目类别:
Regulatory Networks of Helicobacter pylori
幽门螺杆菌的调节网络
  • 批准号:
    7737880
  • 财政年份:
    2006
  • 资助金额:
    $ 22.9万
  • 项目类别:
Regulatory Mechanisms of Helicobacter pylori
幽门螺杆菌的调节机制
  • 批准号:
    8710811
  • 财政年份:
    2005
  • 资助金额:
    $ 22.9万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 22.9万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 22.9万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 22.9万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 22.9万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 22.9万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 22.9万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 22.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 22.9万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 22.9万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 22.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了